Pacific Smiles Group Limited (ASX: PSQ) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Pacific Smiles Group Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Pacific Smiles Group Limited (ASX: PSQ)
Latest News
Healthcare Shares
Dental group receives takeover bid at a handy premium
Dividend Investing
8 ASX All Ords shares with ex-dividend dates next week
Mergers & Acquisitions
2 OTHER ASX shares rocketing on takeover offers today
Earnings Results
2 small ASX healthcare shares sprouting green after FY24 results
Share Gainers
Why Boss Energy, Pacific Smiles, Perpetual, and ResMed shares are racing higher
Mergers & Acquisitions
Why this ASX All Ords stock is sparkling 15% brighter today
Mergers & Acquisitions
Guess which ASX All Ords share just rocketed 18% on takeover news
Earnings Results
4 ASX healthcare shares charging higher on positive earnings updates
Share Market News
5 ASX All Ords shares just upgraded by top brokers
Healthcare Shares
'Highly sought-after': 3 ASX healthcare shares ready to roar again
Broker Notes
'Revenues up 59%': 3 small-cap ASX shares rocketing right now (and set for more gains)
Dividend Investing
4 ASX All Ordinaries shares trading ex-dividend on Wednesday
Frequently Asked Questions
-
Yes, Pacific Smiles Group has historically paid one or two fully franked shareholder dividends a year.
-
Pacific Smiles Group Limited list on the ASX on 21 November 2014.
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 24 Sep 2024 | $0.0325 | 100.00% | Final | 10 Oct 2024 |
| 21 Mar 2024 | $0.0210 | 100.00% | Interim | 05 Apr 2024 |
| 21 Sep 2023 | $0.0227 | 100.00% | Final | 09 Oct 2023 |
| 22 Mar 2023 | $0.0035 | 100.00% | Interim | 06 Apr 2023 |
| 24 Mar 2021 | $0.0240 | 100.00% | Interim | 09 Apr 2021 |
| 18 Mar 2020 | $0.0240 | 100.00% | Interim | 01 May 2020 |
| 18 Sep 2019 | $0.0350 | 100.00% | Final | 04 Oct 2019 |
| 18 Mar 2019 | $0.0230 | 100.00% | Interim | 05 Apr 2019 |
| 19 Sep 2018 | $0.0380 | 100.00% | Final | 05 Oct 2018 |
| 16 Mar 2018 | $0.0230 | 100.00% | Interim | 04 Apr 2018 |
| 14 Sep 2017 | $0.0000 | 100.00% | Final | 03 Oct 2017 |
| 15 Sep 2016 | $0.0350 | 100.00% | Final | 04 Oct 2016 |
| 15 Mar 2016 | $0.0200 | 100.00% | Interim | 01 Apr 2016 |
PSQ ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Pacific Smiles Group Limited
Pacific Smiles Group Limited (ASX: PSQ) operates more than 120 dental centres nationally while more than 800 dentists operate their practices under the company's framework. In those practices, Pacific Smiles provides facilities, dental equipment, and support staff, while dental practitioners maintain clinical autonomy. The group owns and operates Pacific Smiles Dental and nib Dental Care centres across Australia's east coast and also manages operations of HBF Dental Centres in Western Australia.
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Brent Cubis | Non-Executive Director | Oct 2024 |
Mr Cubis was Chief Financial Officer at several healthcare and multisite businesses including Cochlear Ltd, National Home Doctor Service Ltd, Fitness First Ltd and Chris O'Brien Lifehouse Ltd. Following his executive career, he has held several non-executive director roles and is currently a Non-Executive Director on the boards of AI Media, ARN Media, Silverchain Group and Austal Ltd and is the Chair of the Audit & Risk Committee for each of these companies. In his spare time, he sits on the board of not-for-profit Canteen, an organization in Australia dedicated to providing tailored support for young people impacted by cancer. He is Chairman of the Risk Committee.
|
| Mr Steven Rubic | Non-Executive Director | May 2023 |
Mr Rubic has experience as a Non-Executive Director and is currently Deputy Chair of InvoCare funerals & crematoria business, a Non-Executive Director of the Mater Hospitals Group, and Catholic Healthcare Limited governing its retirement living & residential aged care business. Previously, Steven has chaired organizations including the NSW Private Hospitals Association and Monte Sant' Angelo College. His board leadership extends to roles at the Garvan Institute of Medical Research, the Chris O'Brien Lifehouse, the Macquarie University Council and the Health Industry Superannuation Plan. With over 25 years of executive leadership, Steven has held CEO positions at St Vincent's & Mater Health Sydney, I-MED Radiology Network and Healthscope. He is a member of the Risk Committee.
|
| Ms Tara Hariharan | Non-Executive Director | Dec 2024 |
Ms Hariharan is an Investment Manager at Genesis Capital. Prior to this, she was a management consultant at Bain & Company, and has worked across the healthcare, financial services, and not-for-profit sectors. Tara is currently the Director of Genesis Capital portfolio company Impression Dental Group.
|
| Dr Michael Caristo | Non-Executive ChairmanNon-Executive Director | Dec 2024 |
Dr Caristo is a Founding Partner of Genesis Capital. Before establishing Genesis Capital, he was an investment professional at an Australian private equity firm and served as a non-executive director on several portfolio businesses. Dr Caristo began his career at Bain & Company, where he specialized in transaction services. He is also a contributor in the field of stem-cell research. Michael is currently director of Genesis Capital portfolio companies Sana Health Group, Impression Dental, Crux Biolabs, Syntro and Momentum Research as well as a former director of Avance, Agilex and SmartClinics. He is a member of the Risk Management Committee.
|
| Mr Christopher(Chris) Yoo | Non-Executive Director | Dec 2024 |
Mr Yoo is a Founding Partner of Genesis Capital. Prior to Genesis Capital, he was a Partner, member of the investment committee and Principal at globally recognized private equity firms. Chris has held numerous directorships and board roles at various companies and currently serves as a Director of Genesis Capital portfolio companies General Homecare, Therapy Pro, HealthBright, Lifecare Consultants, and Southern Cross Support Services. He is a Member of the Risk Management Committee.
|
| Mr Euh(David) Hwang | Company Secretary | Feb 2025 |
-
|
| Ms Elizabeth Spooner | Company Secretary | Feb 2025 |
-
|
| Martin White | Chief Financial Officer |
-
|
|
| Euh(David) Hwang | Company Secretary |
-
|
|
| Elizabeth Spooner | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Beam Dental Bidco Pty Ltd | 144,273,813 | 89.27% |
| Alison Jane Hughes | 16,178,947 | 10.01% |
| Mr Allan Graeme Roberts | 252,124 | 0.16% |
| HSBC Custody Nominees (Australia) Limited | 166,607 | 0.10% |
| BNP Paribas Nominees Pty Ltd (IB Au Noms Retail Client) | 93,895 | 0.02% |
| Annabash Pty Limited (The Annabash Investment A/C) | 44,800 | 0.03% |
| Citicorp Nominees Pty Limited | 27,327 | 0.02% |
| Maralda Pty Limited | 15,385 | 0.01% |
| Mr Peter Lawrence Gisz | 15,369 | 0.01% |
| HSBC Custody Nominees (Australia) Limited A/C 2 | 15,193 | 0.01% |
| Mr Simon Richard Ward & Miss Collette Keenan (Ward Keenan S/F A/C) | 14,040 | 0.01% |
| Mr Anthony Michael Donato & Mrs Palmina Donato (Donato Executive SF A/C) | 13,500 | 0.01% |
| Mr Ross John Hughes | 13,094 | 0.01% |
| Miss Leanne E Clark | 12,820 | 0.01% |
| A & H Nominees Pty Ltd (HJ Superannuation Fund A/C) | 12,486 | 0.01% |
| Mr Matthew Learn | 11,230 | 0.01% |
| Warbont Nominees Pty Ltd (Unpaid Entrepot A/C) | 10,138 | 0.01% |
| Ms Petrina Fawcett | 9,348 | 0.01% |
| Limits Pty Ltd (Duncan Gamble Family A/C) | 9,146 | 0.01% |
| Kayday Pty Ltd (Kayday Super Fund A/C) | 8,768 | 0.01% |